Diagnosing Opportunity
Scientific instrument makers bolster positions in the growing market for human clinical health testing
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
August 27, 2012 Cover
Volume 90, Issue 35
Scientific instrument makers bolster positions in the growing market for human clinical health testing
Cover image:
Credit:
Scientific instrument makers bolster positions in the growing market for human clinical health testing
How an academic pursuit to understand epoxomicin became the cancer treatment carfilzomib
Italian firms are investing aggressively in R&D and building plants to make chemicals from renewable feedstocks
IUPAC effort sets parameters for structural interaction seen in materials science and biology
LanzaTech stakes out a renewables path that does not require biobased feedstocks
Synthetic marijuana compounds, two stimulants, and nine hallucinogens are outlawed in U.S.
ACS Meeting News: Peptide anchors make polymeric particles bind blood cells together